» Articles » PMID: 9928482

Alternative Splicing of Pre-mRNA: Developmental Consequences and Mechanisms of Regulation

Overview
Journal Annu Rev Genet
Publisher Annual Reviews
Specialty Genetics
Date 1999 Feb 3
PMID 9928482
Citations 218
Authors
Affiliations
Soon will be listed here.
Abstract

Alternative splicing of pre-mRNAs is a powerful and versatile regulatory mechanism that can effect quantitative control of gene expression and functional diversification of proteins. It contributes to major developmental decisions and also to fine tuning of gene function. Genetic and biochemical approaches have identified cis-acting regulatory elements and trans-acting factors that control alternative splicing of specific pre-mRNAs. Both approaches are contributing to an understanding of their mode of action. Some alternative splicing decisions are controlled by specific factors whose expression is highly restricted during development, but others may be controlled by more modest variations in the levels of general factors acting cooperatively or antagonistically. Certain factors play active roles in both constitutive splicing and regulation of alternative splicing. Cooperative and antagonistic effects integrated at regulatory elements are likely to be important for specificity and for finely tuned differences in cell-type-specific alternative splicing patterns.

Citing Articles

RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs.

Krishnamoorthy G, Glover A, Untch B, Sigcha-Coello N, Xu B, Vukel D J Exp Med. 2025; 222(5).

PMID: 39992626 PMC: 11849553. DOI: 10.1084/jem.20241029.


RBM10 loss induces aberrant splicing of cytoskeletal and extracellular matrix mRNAs and promotes metastatic fitness.

Krishnamoorthy G, Glover A, Untch B, Sigcha-Coello N, Xu B, Vukel D bioRxiv. 2024; .

PMID: 39026820 PMC: 11257529. DOI: 10.1101/2024.07.09.602730.


When Livestock Genomes Meet Third-Generation Sequencing Technology: From Opportunities to Applications.

Liu X, Zheng J, Ding J, Wu J, Zuo F, Zhang G Genes (Basel). 2024; 15(2).

PMID: 38397234 PMC: 10888458. DOI: 10.3390/genes15020245.


Introns and Their Therapeutic Applications in Biomedical Researches.

Haddad-Mashadrizeh A, Mirahmadi M, Taghavizadeh Yazdi M, Gholampour-Faroji N, Bahrami A, Zomorodipour A Iran J Biotechnol. 2024; 21(4):e3316.

PMID: 38269198 PMC: 10804063. DOI: 10.30498/ijb.2023.334488.3316.


A patient-derived organoid-based study identified an ASO targeting SNORD14E for endometrial cancer through reducing aberrant FOXM1 Expression and β-catenin nuclear accumulation.

Chen X, Liu X, Li Q, Lu B, Xie B, Ji Y J Exp Clin Cancer Res. 2023; 42(1):230.

PMID: 37667311 PMC: 10478245. DOI: 10.1186/s13046-023-02801-2.